Zoulim F - Search Results

1

The variability of hepatitis B envelope is associated with HBs antigen persistence in either chronic or acute HBV genotype A infection.

Eschlimann M, Malvé B, Velay A, Fenaux H, Berger S, Frippiat JP, Zoulim F, Bensenane M, Bronowicki JP, Goehringer F, May T, Jeulin H, Schvoerer E. Eschlimann M, et al. Among authors: zoulim f. J Clin Virol. 2017 Sep;94:115-122. doi: 10.1016/j.jcv.2017.08.001. Epub 2017 Aug 5. J Clin Virol. 2017. PMID: 28822954

2

A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection.

Zoulim F. Zoulim F. Drug Saf. 2002;25(7):497-510. doi: 10.2165/00002018-200225070-00004. Drug Saf. 2002. PMID: 12093308 Review.

3

Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays.

Jeantet D, Chemin I, Mandrand B, Tran A, Zoulim F, Merle P, Trepo C, Kay A. Jeantet D, et al. Among authors: zoulim f. J Med Virol. 2004 Aug;73(4):508-15. doi: 10.1002/jmv.20119. J Med Virol. 2004. PMID: 15221893

4

Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon-ribavirin therapy.

Vuillermoz I, Khattab E, Sablon E, Ottevaere I, Durantel D, Vieux C, Trepo C, Zoulim F. Vuillermoz I, et al. Among authors: zoulim f. J Med Virol. 2004 Sep;74(1):41-53. doi: 10.1002/jmv.20144. J Med Virol. 2004. PMID: 15258967

5

Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection.

Zoulim F. Zoulim F. Antiviral Res. 2004 Oct;64(1):1-15. doi: 10.1016/j.antiviral.2004.07.003. Antiviral Res. 2004. PMID: 15451174 Review.

6

A quasi-monoclonal anti-HBs response can lead to immune escape of 'wild-type' hepatitis B virus.

Margeridon S, Lachaux A, Trepo C, Zoulim F, Kay A. Margeridon S, et al. Among authors: zoulim f. J Gen Virol. 2005 Jun;86(Pt 6):1687-1693. doi: 10.1099/vir.0.80810-0. J Gen Virol. 2005. PMID: 15914846

7

Assessment of treatment efficacy in HBV infection and disease.

Zoulim F. Zoulim F. J Hepatol. 2006;44(1 Suppl):S95-9. doi: 10.1016/j.jhep.2005.11.020. Epub 2005 Nov 28. J Hepatol. 2006. PMID: 16352365 Review.

8

Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing.

Durantel D, Brunelle MN, Gros E, Carrouée-Durantel S, Pichoud C, Villet S, Trepo C, Zoulim F. Durantel D, et al. Among authors: zoulim f. J Clin Virol. 2005 Dec;34 Suppl 1:S34-43. doi: 10.1016/s1386-6532(05)80008-3. J Clin Virol. 2005. PMID: 16461221 Review.

9

Entecavir: a new treatment option for chronic hepatitis B.

Zoulim F. Zoulim F. J Clin Virol. 2006 May;36(1):8-12. doi: 10.1016/j.jcv.2006.01.010. Epub 2006 Mar 3. J Clin Virol. 2006. PMID: 16515882 Review.

10

Antiviral therapy of chronic hepatitis B.

Zoulim F. Zoulim F. Antiviral Res. 2006 Sep;71(2-3):206-15. doi: 10.1016/j.antiviral.2006.04.003. Epub 2006 Apr 25. Antiviral Res. 2006. PMID: 16716414 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

644 results

Search Page

Filters